Vaccination Booster Dose Combinations For Priority Group A2 & A3

Phase I: The vaccination rollout shall include the following and shall commence on November 22, 2021:

A. Administration of booster doses to Priority Group A2: Senior Citizens, either a homologous or heterologous dose.

B. Administration of third (additional) doses as part of the extended primary vaccination series to Priority Group A3: Individuals with Comorbidities in immunocompromised state, either a homologous or heterologous dose. Those in immunocompromised state are:

1. Immunodeficiency state
2. HIV
3. Active cancer or malignancy
4. Transplant recipients
5. Patients under immunosuppressives